Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weitz

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Digitally Delivered, Systemically Challenged: A Qualitative Study of Health System Readiness for Digital CareLaurel O'Connor, Leah Dunkel, Andrew C Weitz, et al.
The Journal of Parasitology|June 2, 2007
Human pseudoterranovosis, an emerging infection in ChileP Torres, M I Jercic, J C Weitz, et al.
Revista Medica De Chile|July 1, 1985
[Cryptosporidium in Chile]J C Weitz, R Mercado, R Tassara, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
Interphase gap decreases electrical stimulation threshold of retinal ganglion cellsA C Weitz, M R Behrend, M S Humayun, et al.
Acta Haematologica|October 31, 2019
A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic AnemiaCaroline I Piatek, Hillel Bocian, Sandra Algaze, et al.
Investigational New Drugs|November 27, 2002
Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group studyCary A Presant, Joth Jacobson, Walter Wolf, et al.
Journal of the American Chemical Society|October 11, 2016
NaClO-Generated Iron(IV)oxo and Iron(V)oxo TAMLs in Pure WaterMatthew R Mills, Andrew C Weitz, Michael P Hendrich, et al.
Transfusion|May 20, 2015
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximabMark Boonyasampant, Ilene C Weitz, Brian Kay, et al.
Inorganic Chemistry|July 1, 2020
Electronic State of the His/Tyr-Ligated Heme of BthA by Mössbauer and DFT AnalysisAndrew C Weitz, Saborni Biswas, Kim Rizzolo, et al.
Hematology (Amsterdam, Netherlands)|August 29, 2020
Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumabIoannis Tomazos, J Rafael Sierra, Karissa M Johnston, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Digitally Delivered, Systemically Challenged: A Qualitative Study of Health System Readiness for Digital CareLaurel O'Connor, Leah Dunkel, Andrew C Weitz, et al.
The Journal of Parasitology|June 2, 2007
Human pseudoterranovosis, an emerging infection in ChileP Torres, M I Jercic, J C Weitz, et al.
Revista Medica De Chile|July 1, 1985
[Cryptosporidium in Chile]J C Weitz, R Mercado, R Tassara, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
Interphase gap decreases electrical stimulation threshold of retinal ganglion cellsA C Weitz, M R Behrend, M S Humayun, et al.
Acta Haematologica|October 31, 2019
A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic AnemiaCaroline I Piatek, Hillel Bocian, Sandra Algaze, et al.
Investigational New Drugs|November 27, 2002
Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group studyCary A Presant, Joth Jacobson, Walter Wolf, et al.
Journal of the American Chemical Society|October 11, 2016
NaClO-Generated Iron(IV)oxo and Iron(V)oxo TAMLs in Pure WaterMatthew R Mills, Andrew C Weitz, Michael P Hendrich, et al.
Transfusion|May 20, 2015
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximabMark Boonyasampant, Ilene C Weitz, Brian Kay, et al.
Inorganic Chemistry|July 1, 2020
Electronic State of the His/Tyr-Ligated Heme of BthA by Mössbauer and DFT AnalysisAndrew C Weitz, Saborni Biswas, Kim Rizzolo, et al.
Hematology (Amsterdam, Netherlands)|August 29, 2020
Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumabIoannis Tomazos, J Rafael Sierra, Karissa M Johnston, et al.
Pageof 12